Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2022 Apr 7;15:329–330. doi: 10.2147/OTT.S369352

The Silencing of LncRNA-H19 Decreases Chemoresistance of Human Glioma Cells to Temozolomide by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway [Retraction]

PMCID: PMC9000918  PMID: 35418757

Jia L, Tian Y, Chen Y, Zhang G. Onco Targets Ther. 2018;11:313–321.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of flow cytometry images in Figure 1 with images from other articles. Specifically,

The authors did not respond to our queries and were unable to provide any original data for their study.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES